Robert L. Janiczek - Concepedia

Author

Robert L. Janiczek

Also Known As

Janiczek, RL, Janiczek, Robert, R L Janiczek, R. Janiczek, R. L. Janiczek, R.L. Janiczek, Robert Janiczek, Robert L Janiczek, Robert L. Janiczek

Publications

634

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University College London University of Cambridge University of Edinburgh Cambridge University Hospitals NHS Foundation Trust

About

Robert L. Janiczek is an author at GlaxoSmithKline (United Kingdom) specializing in medical imaging, radiology, and biomedical imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	3	3	92
2	Medicine	3	3	108
3	Biomedical Engineering	3	3	92
4	Health Sciences	1	1	11
5	Immunology	1	1	27

Robert L. Janiczek

Publications

598

Citations

H-Index

Page 1

	Year	Citations
Improved arterial spin labeling after myocardial infarction in mice using cardiac and respiratory gated look-locker imaging with fuzzy C-means clustering Moriel Vandsburger, Robert L. Janiczek, Yaqin Xu, Magnetic Resonance in Medicine Heart FailureEngineeringAdvanced ImagingFuzzy C-meansBiomedical Engineering	2010	65
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials Valeria Ricotti, Matthew R. Evans, Christopher D. J. Sinclair, PLoS ONE	2016	65
Simultaneous <i>T</i><sub>2</sub> and lipid quantitation using IDEAL‐CPMG Robert L. Janiczek, Giulio Gambarota, Christopher D. J. Sinclair, Magnetic Resonance in Medicine	2011	50
Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy Ami Mankodi, Courtney Bishop, Sungyoung Auh, Neuromuscular Disorders	2016	48
Three‐dimensional phase contrast angiography of the mouse aortic arch using spiral MRI Robert L. Janiczek, Brett R. Blackman, Rahul Roy, Magnetic Resonance in Medicine	2011	41
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, BMC Cardiovascular Disorders	2022	32
Semi-Automated Analysis of Diaphragmatic Motion with Dynamic Magnetic Resonance Imaging in Healthy Controls and Non-Ambulant Subjects with Duchenne Muscular Dystrophy Courtney Bishop, Valeria Ricotti, Christopher D. J. Sinclair, Frontiers in Neurology	2018	29
Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers Beat M. Jucker, Edward J. Fuchs, Sarah Lee, British Journal of Clinical Pharmacology	2021	29
Effectively Measuring Exercise‐Related Variations in T1ρ and <scp>T2</scp> Relaxation Times of Healthy Articular Cartilage Dimitri A. Kessler, James Mackay, Scott D. McDonald, Journal of Magnetic Resonance Imaging	2020	27
MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study Mark C. Genovese, Mario Berkowitz, Philip G. Conaghan, The Lancet Rheumatology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseGranulocyte	2020	27

Page 1